Printer Friendly Printer Friendly   | Text Size Decrease Text Size Increase Text Size

Press Releases

You Narrowed By: Financial Release
Showing 1-35 of 62
First 1   2   Next   Last

2010
August

8/30/10 Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference

July

7/22/10 Abbott to Present at Wedbush Securities Life Sciences Best Ideas MAC Conference
7/21/10 Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010
7/7/10 Abbott Hosts Conference Call for Second-Quarter Earnings

June

6/11/10 Abbott Declares 346th Consecutive Quarterly Dividend
6/3/10 Abbott to Present at Goldman Sachs 31st Annual Global Healthcare Conference

May

5/5/10 Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference

April

4/21/10 Abbott Reports Strong First Quarter Results; Forecasts Double-Digit Ongoing Earnings Growth in 2010

March

3/31/10 Abbott Hosts Conference Call for First-Quarter Earnings
3/11/10 Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron® Depot for the Palliative Treatment of Advanced Prostate Cancer

February

2/24/10 Abbott to Present at Cowen and Company Annual Health Care Conference
2/19/10 Abbott Announces 10 Percent Increase in Quarterly Dividend

January

1/27/10 Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010
1/4/10 Abbott to Present at J.P. Morgan Healthcare
1/4/10 Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2009 Earnings

2009
December

12/11/09 Abbott Declares 344th Consecutive Quarterly Dividend

October

10/14/09 Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009

September

9/24/09 Abbott Hosts Conference Call for Third-Quarter Earnings
9/24/09 Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
9/17/09 Abbott Declares 343rd Consecutive Quarterly Dividend

August

8/31/09 Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference

July

7/15/09 Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

June

6/24/09 Abbott Hosts Conference Call for Second-Quarter Earnings
6/12/09 Abbott Declares 342nd Consecutive Quarterly Dividend
6/1/09 Abbott to Present at Goldman Sachs Global Healthcare Conference

April

4/15/09 Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009

March

3/25/09 Abbott Hosts Conference Call for First-Quarter Earnings
3/4/09 Abbott to Present at Cowen Annual Health Care Conference

February

2/27/09 Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of its AMO Subsidiary
2/26/09 Abbott Completes Acquisition of Advanced Medical Optics
2/25/09 Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
2/24/09 Abbott to Present at Barclays Global Healthcare Conference
2/20/09 Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
2/20/09 Abbott Announces 11 Percent Increase in Quarterly Dividend
2/6/09 Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
First 1   2   Next   Last

Narrow by Year

Narrow to Show

Survey

We would appreciate your feedback on our News and Media section. Please participate in our online survey.

Newsfeed

RSS

Subscribe to Abbott's Newsfeeds and get up-to-the-minute news from all of Abbott's businesses.


Home | Select a Country | Site Map | Contact Us | Privacy Policy | Terms of Use

Copyright © 2006, 2010 Abbott Laboratories. Abbott Park, Illinois, U.S.A.


Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.